Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Natals Inc. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to examiner ARMATO JR, DENNIS IGNATIUS. The company's current prosecution is limited to a single distinct examiner and a sole distinct art unit, indicating a highly specific technical focus for its pharmaceutical research.
ARMATO JR, DENNIS IGNATIUS is the busiest examiner with 1 pending office action. For the practitioner, this means prosecution is currently focused on an individual examiner relationship. This narrow focus requires a strategy tailored to the specific examination style and technical requirements of this examiner. Because there are no other active matters, the company's entire prosecution standing at the USPTO depends on the outcome of this single case. The practitioner must carefully monitor the procedural tendencies of the assigned art unit to ensure a favorable result.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARMATO JR, DENNIS IGNATIUS | 1 | 42.9% | +80.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18424585 | MULTIBIOTIC SUPPLEMENTS | ARMATO JR, DENNIS IGNATIUS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18424585 | MULTIBIOTIC SUPPLEMENTS | ARMATO JR, DENNIS IGNATIUS | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18424585 | MULTIBIOTIC SUPPLEMENTS | ARMATO JR, DENNIS IGNATIUS | 1651 | §101§102§103§112 | Non-Final OA | — | Pending | Jan 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNatals Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Dennis Ignatius Armato Jr. has the most, with 1 of Natals Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
